(Q40711010)

23 September 2017

1 reference

title

Interleukin-12: a recently discovered cytokine with potential for enhancing cell-mediated immune responses to tumors (English)

1 reference

23 September 2017

Gately MK

1

1 reference

23 September 2017

publication date

1 January 1993

1 reference

23 September 2017

1 reference

23 September 2017

volume

11

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

500-506

1 reference

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Molecular characterization of interleukin 12

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Molecular cloning and expression of an IL-6 signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Regulation of human cytolytic lymphocyte responses by interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309018881

10.3109/07357909309018881

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference